The European Medicines Agency (EMA) has accepted Takeda Pharmaceutical Company Limited's filing packages for its dengue vaccine candidate (TAK-003), which is being investigated to prevent dengue due to any dengue virus serotype in individuals ages ...
from Google Alert - health https://ift.tt/2OYGdVn
via IFTTT
0 comments:
Post a Comment